Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Micro Cap & Branchenriese: Heute rein? - Partnerschaft entfacht Übernahmefantasien!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EW0P | ISIN: US00808Y4061 | Ticker-Symbol: EJU0
Tradegate
22.01.25
16:00 Uhr
0,605 Euro
-0,020
-3,20 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
AETHLON MEDICAL INC Chart 1 Jahr
5-Tage-Chart
AETHLON MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,5900,61022.01.
0,5800,61022.01.

Aktuelle News zur AETHLON MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.01.AETHLON MEDICAL INC - 8-K, Current Report11
20.12.24AETHLON MEDICAL INC - 8-K, Current Report18
15.11.24AETHLON MEDICAL INC - S-8, Securities to be offered to employees in employee benefit plans2
13.11.24AETHLON MEDICAL INC - 10-Q, Quarterly Report-
13.11.24Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update100Achieves Key Milestone with Enrollment of First Two Patients in the Safety, Feasibility, and Dose Finding Study of Aethlon's Hemopurifier® in Patients with Solid...
► Artikel lesen
12.11.24An Overview of Aethlon Medical's Earnings2
11.11.24Aethlon Medical, Inc.: Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in Australia117Patient Enrolled at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital Aethlon's Trial is a Safety, Feasibility, and Dose Finding Study of the Hemopurifier®...
► Artikel lesen
AETHLON MEDICAL Aktie jetzt für 0€ handeln
02.10.24Aethlon Medical Expands Equity Incentive Plan by 3 Million shares2
02.10.24Aethlon Medical erweitert Aktienbeteiligungsprogramm um 3 Millionen Aktien4
02.10.24AETHLON MEDICAL INC - 8-K, Current Report1
19.09.24Aethlon Hemopurifier study receives ethics approval in India3
19.09.24AETHLON MEDICAL INC - 8-K, Current Report3
16.09.24Aethlon Gains on Product News-
16.09.24Aethlon begins patient enrollment in Hemopurifier cancer trial1
15.08.24AETHLON MEDICAL INC - 10-K/A, Annual Report3
15.08.24Earnings call: Aethlon Medical reports Q1 2025 financials, updates on trials2
14.08.24AETHLON MEDICAL INC - 10-Q, Quarterly Report2
14.08.24Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update149Received Two Australian Ethics Committee Approvals for a Safety, Feasibility, and Dose Finding Study of Aethlon's Hemopurifier® in Patients with Solid Tumors Not Responding to Anti-PD-1 Antibodies...
► Artikel lesen
13.08.24Aethlon Medical Q1 2025 Earnings Preview2
12.08.24Aethlon Enjoys Slight Gains on Ethics Approval-
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1